<unk> , also known as VBC-COV19-154 in Vietnam, is a COVID-19 vaccine candidate developed by<unk> urus Therapeutics. For its development,<unk> urus collaborated with Vinbiocare, a Vietnamese company, for support with clinical trials and manufacturing.
ARCT-154
TPA-023
BGR-34
BIM-1
COVAX-19
ALG1-CDG
VIR-576
STS-135 